Jiang Wen, Li Jie, Cai Yuefang, Liu Wenchen, Chen Mei, Xu Xiaoying, Deng Minzhen, Sun Jingbo, Zhou Lihua, Huang Yan, Wu Shuang, Cheng Xiao
Department of Second Institute of Clinical Medicine, Guangzhou University of Traditional Chinese Medicine, Guangzhou, China.
Department of Anesthesiology, Guangdong Provincial Hospital of Traditional Chinese Medicine/The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.
Front Genet. 2022 Jun 8;13:873230. doi: 10.3389/fgene.2022.873230. eCollection 2022.
Ischemic stroke (IS) is a major neurological disease with high fatality and residual disability burdens. Long noncoding RNAs (lncRNAs) have been found to play an important role in IS. However, the roles and significance of most lncRNAs in IS are still unknown. This study was performed to identify differentially expressed (DE) lncRNAs using a lncRNA microarray in whole blood samples of patients suffering from acute cerebral ischemia. Bioinformatics analyses, including GO, KEGG pathway enrichment analysis, and proximity to putative stroke risk location analysis were performed. The novel lncRNA, ENST00000530525, significantly decreased after IS. Furthermore, we evaluated lncRNA ENST00000530525 expression in cultured hCMEC/D3 cells under oxygen-glucose deprivation/reoxygenation (OGD/R) conditions using fluorescent hybridization (FISH) and quantitative real-time polymerase chain reaction (RT-qPCR) analysis. To investigate the function of lncRNA ENST00000530525, its over-expression (OE) and negative control (NC) plasmids were transfected into hCMEC/D3 cells, and cell viability was detected by a cell counting kit-8 (CCK-8) assay after OGD/R. LncRNA ENST00000530525 and ANO1 expression were investigated using RT-qPCR and immunofluorescence. For blood-brain barrier (BBB) permeability, FITC-dextran transendothelial permeability assay and tight junction (TJ) protein immunofluorescence assays were performed. There were 3352 DE lncRNAs in the blood samples of acute IS patients. The validation results were consistent with the gene chip data. The GO and KEGG results showed that these lncRNAs were mainly related to oxygen and glucose metabolism, leukocyte transendothelial migration, mitophagy and cellular senescence. Among these, lncRNA ENST00000530525 was the most highly downregulated lncRNA and it was mapped within the IS-associated gene anoctamin-1 (ANO1). We further found that lncRNA ENST00000530525 was downregulated in hCMEC/D3 cells under 4 h OGD and 20 h reoxygenation (OGD4/R20) conditions. Upregulating lncRNA ENST00000530525 by plasmid transfection decreased cell viability while increasing ANO1 expression and it contributed to BBB injury in hCMEC/D3 cells after OGD4/R20. The lncRNA ENST00000530525 might play deleterious roles in post-stroke pathogenesis. These results show that some DE lncRNAs in humans participate through characteristic roles in post-stroke pathogenesis; thus, the roles and significance of some novel lncRNAs in IS warrant further study.
缺血性中风(IS)是一种具有高致死率和严重致残负担的主要神经疾病。长链非编码RNA(lncRNAs)已被发现参与IS的发病机制。然而,大多数lncRNAs在IS中的作用和意义仍不清楚。本研究旨在利用lncRNA芯片,鉴定急性脑缺血患者全血样本中差异表达的(DE)lncRNAs。我们进行了生物信息学分析,包括基因本体(GO)、京都基因与基因组百科全书(KEGG)通路富集分析,以及与假定的中风风险位置的邻近性分析。新的lncRNA,ENST00000530525,在IS后显著下降。此外,我们使用荧光杂交(FISH)和定量实时聚合酶链反应(RT-qPCR)分析,评估了lncRNA ENST00000530525在氧糖剥夺/复氧(OGD/R)条件下培养的人脑血管内皮细胞(hCMEC/D3)中的表达。为了研究lncRNA ENST00000530525的功能,将其过表达(OE)和阴性对照(NC)质粒转染到hCMEC/D3细胞中,并在OGD/R后通过细胞计数试剂盒-8(CCK-8)测定法检测细胞活力。使用RT-qPCR和免疫荧光法研究lncRNA ENST00000530525和ANO1的表达。对于血脑屏障(BBB)通透性,进行了异硫氰酸荧光素-葡聚糖跨内皮通透性测定和紧密连接(TJ)蛋白免疫荧光测定。急性IS患者的血液样本中有3352个DE lncRNAs。验证结果与基因芯片数据一致。GO和KEGG结果表明,这些lncRNAs主要与氧和葡萄糖代谢、白细胞跨内皮迁移、线粒体自噬和细胞衰老有关。其中,lncRNA ENST00000530525是下调最显著的lncRNA,它定位在与IS相关的anoctamin-1(ANO1)基因内。我们进一步发现,在4小时OGD和20小时复氧(OGD4/R20)条件下,hCMEC/D3细胞中lncRNA ENST00000530525表达下调。通过质粒转染上调lncRNA ENST00000530525可降低细胞活力,同时增加ANO1表达,并导致OGD4/R20后hCMEC/D3细胞的BBB损伤。lncRNA ENST00000530525可能在中风后发病机制中起有害作用。这些结果表明,人类中的一些DE lncRNAs通过在中风后发病机制中的特定作用参与其中;因此,一些新的lncRNAs在IS中的作用和意义值得进一步研究。